Colecchia, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.121
NA - Nord America 10.271
EU - Europa 7.041
SA - Sud America 2.848
AF - Africa 288
OC - Oceania 92
Continente sconosciuto - Info sul continente non disponibili 10
Totale 31.671
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.970
SG - Singapore 2.959
CN - Cina 2.823
SE - Svezia 2.304
BR - Brasile 2.264
HK - Hong Kong 2.000
VN - Vietnam 1.513
IT - Italia 1.084
GB - Regno Unito 914
FI - Finlandia 857
KR - Corea 538
RU - Federazione Russa 418
DE - Germania 304
AR - Argentina 238
PL - Polonia 238
ID - Indonesia 221
BG - Bulgaria 207
IN - India 175
FR - Francia 169
BD - Bangladesh 160
EC - Ecuador 130
JP - Giappone 127
CA - Canada 112
MX - Messico 112
NL - Olanda 102
AU - Australia 81
TR - Turchia 78
IQ - Iraq 73
ZA - Sudafrica 69
UA - Ucraina 66
PK - Pakistan 63
IE - Irlanda 59
CO - Colombia 52
AT - Austria 49
ES - Italia 48
EG - Egitto 47
AE - Emirati Arabi Uniti 42
CL - Cile 42
PY - Paraguay 42
MA - Marocco 40
UZ - Uzbekistan 39
LT - Lituania 38
RO - Romania 37
PH - Filippine 36
IR - Iran 30
TN - Tunisia 30
VE - Venezuela 30
TH - Thailandia 29
KE - Kenya 25
PE - Perù 22
BE - Belgio 21
AZ - Azerbaigian 19
MY - Malesia 19
NP - Nepal 19
UY - Uruguay 19
JO - Giordania 17
SA - Arabia Saudita 17
CZ - Repubblica Ceca 16
DZ - Algeria 16
TW - Taiwan 14
BH - Bahrain 13
JM - Giamaica 13
KZ - Kazakistan 13
CH - Svizzera 12
MK - Macedonia 12
LB - Libano 11
PT - Portogallo 11
AL - Albania 10
CR - Costa Rica 10
DO - Repubblica Dominicana 10
GR - Grecia 10
PA - Panama 10
SC - Seychelles 10
BO - Bolivia 9
IL - Israele 9
KG - Kirghizistan 9
NZ - Nuova Zelanda 9
NG - Nigeria 8
ET - Etiopia 7
GH - Ghana 7
OM - Oman 7
PS - Palestinian Territory 7
QA - Qatar 7
DK - Danimarca 6
EU - Europa 6
HN - Honduras 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
GT - Guatemala 5
HU - Ungheria 5
MD - Moldavia 5
TT - Trinidad e Tobago 5
BB - Barbados 4
BY - Bielorussia 4
CY - Cipro 4
GE - Georgia 4
HR - Croazia 4
KH - Cambogia 4
KW - Kuwait 4
NI - Nicaragua 4
Totale 31.589
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.968
Santa Clara 1.937
Stockholm 1.792
Singapore 1.612
Ashburn 1.112
Helsinki 817
Hefei 773
Fairfield 645
London 619
San Jose 578
Ho Chi Minh City 513
Nyköping 472
Seoul 449
Beijing 440
The Dalles 383
Hanoi 355
Chandler 331
São Paulo 265
Wilmington 260
Los Angeles 241
Princeton 239
Woodbridge 232
San Diego 228
Warsaw 224
New York 217
Houston 213
Sofia 204
Cambridge 203
Council Bluffs 190
Shanghai 183
Buffalo 174
Seattle 160
Chicago 152
Milan 133
Jakarta 115
Modena 96
Moscow 91
Da Nang 81
Dallas 78
Bologna 77
Porto Alegre 73
Rome 73
Rio de Janeiro 71
Salt Lake City 69
Melbourne 68
Redondo Beach 67
Haiphong 66
Tokyo 64
Nuremberg 63
Lauterbourg 58
Southend 57
Orem 56
Ann Arbor 55
Bupyeong-gu 52
Dublin 50
Belo Horizonte 49
Frankfurt am Main 49
Kent 44
Quito 43
Elk Grove Village 42
Guangzhou 42
Munich 42
Amsterdam 41
Curitiba 39
Biên Hòa 38
Guayaquil 38
Jacksonville 38
Bremen 37
Jersey City 36
Chennai 34
Johannesburg 34
Tashkent 34
Hải Dương 32
Reggio Emilia 32
Vancouver 31
Dhaka 30
Kilburn 29
Brasília 28
Norwalk 27
Tampa 27
Phoenix 26
Baghdad 25
Campinas 25
Montreal 25
Ninh Bình 24
Buenos Aires 23
Nairobi 22
Vienna 22
Dearborn 21
Thái Bình 21
Lappeenranta 20
Mexico City 20
Salvador 20
Brooklyn 19
Can Tho 19
Bắc Ninh 18
Mashhad 18
Ribeirão Preto 18
Asunción 17
Bangkok 17
Totale 21.130
Salva come PNG Salva come JPEG
Nome #
"Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?" 1.961
Gut Microbiota and Celiac Disease. 308
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 276
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT 260
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 259
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 255
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 252
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 251
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 249
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 242
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 221
Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease 220
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 215
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 214
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 213
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 208
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 201
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 201
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease 200
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 200
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 196
Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives 195
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 194
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 192
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 191
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 190
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients 189
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 187
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 182
Post COVID-19 irritable bowel syndrome 179
Growth and nutritional evaluation in children with chronic liver disease (CLD) before and after liver transplantation 178
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 176
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 175
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations 173
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 172
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma 172
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients 171
Gut microbiota and metabolic syndrome 171
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 169
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 167
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 167
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 166
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 160
Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition 157
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load 157
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 156
The management of endoscopic retrograde cholangiopancreatography related infections risk: results of an italian survey at regional level 156
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma 156
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods 156
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 154
Hepatic steatosis in obese patients: clinical aspects and prognostic significance 154
Gut microbiota and its pathophysiology in disease paradigms 153
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 152
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: A systematic review and meta-analysis 150
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 147
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives 147
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 147
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 147
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 146
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 146
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 146
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 145
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 145
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 142
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 140
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 140
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 140
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis 139
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 139
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference 138
Liver fibrosis by FibroScan(®) independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes 137
Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL) 136
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 136
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 136
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 131
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 130
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 130
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 129
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance 127
Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantation 126
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients 126
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 125
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 125
Corrigendum to “Idiopathic pulmonary fibrosis and intestinal disorders: An observational study” [Ann Diagn Pathol 62 (2023) 152072] (Annals of Diagnostic Pathology (2023) 62, (S1092913422001745), (10.1016/j.anndiagpath.2022.152072)) 124
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study 124
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 122
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 121
Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study 120
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 120
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 120
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma 119
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 117
Prognostic factors for hepatocellular carcinoma recurrence 116
The role of liver and spleen elastography in advanced chronic liver disease 116
Transjugular intrahepatic portosystemic shunt: A case report of rescue management of unrestrainable variceal bleeding in a pregnant woman 116
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 115
Diverticular disease of the colon: new perspectives in symptom development and treatment 114
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: Prevalence, noninvasive diagnosis, and burden on surgical outcomes. 113
Italian consensus conference for colonic diverticulosis and diverticular disease 113
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients 113
Totale 18.210
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.095
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 0 0 0 0 60 12
2021/20222.566 35 27 12 8 34 29 743 185 338 48 754 353
2022/20231.813 307 184 151 85 162 208 46 249 211 30 87 93
2023/20242.351 30 91 133 139 469 157 129 220 364 140 130 349
2024/20257.601 141 33 55 540 1.415 1.030 683 358 1.029 447 611 1.259
2025/202616.877 956 761 1.916 2.725 1.323 1.085 2.194 1.034 3.258 1.434 191 0
Totale 31.982